Tributary

Pan-cancer spatial atlas of tertiary lymphoid structures.

Science (New York, N.Y.)May 2026
Kyung Serk Cho, Yunhe Liu, Guangsheng Pei, Jianfeng Chen, Yibo Dai, Yang Liu, Tieling Zhou, Antoine Bougouin, Alejandra Serrano, Khalida Wani, Akshaya Jadhav, Jimin Min, Sharia Hernandez, Wei Lu, Daiwei Zhang, Jiahui Jiang, Diana Shamsutdinova, Enyu Dai, Fuduan Peng, Ansam Sinjab, Paola A Guerrero, Idania Carolina Lubo Julio, Kai Yu, Helen Clark, Dipen Maru, Mingyao Li, Andrew Futreal, Sanghoon Lee, Luisa Maren Solis Soto, Lulu Shang, Pavlos Msaouel, Jaffer A Ajani, Hannah Beird, Amir A Jazaeri, Alexander J Lazar, Catherine Sautes-Fridman, Wolf H Fridman, Anirban Maitra, Humam Kadara, Jianjun Gao, Padmanee Sharma, Linghua Wang

Tertiary lymphoid structures (TLSs) are critical regulators of antitumor immunity, yet their spatial organization, maturation, and clinical relevance remain incompletely defined across cancers. We analyzed spatial transcriptomics spanning 12 cancer types to construct a pan-cancer TLS atlas and characterized TLS spatial architecture and maturation states. TLS maturation was accompanied by coordinated remodeling of distinct niche cell populations and distance-dependent gradients in tumor programs, orthogonally supported by ultrahigh-plex single-cell spatial profiling. To enable scalable TLS profiling, we trained an artificial intelligence framework that predicts TLS maturation states directly from hematoxylin and eosin-stained images and evaluated it across TCGA and independent therapy cohorts. We further derived a maturation-aware composite score capturing intratumoral TLS state composition, which robustly stratifies patients across cancer and treatment contexts, outperforming conventional TLS metrics.

0
0
Save

Discussion · 0 comments

Markdown
Posting as a Scholar — held to community guidelines

Build the journal club your field actually needs.

Keeping up with new evidence is essential. We're building a better way.

We're looking for Founding Moderators to engage with key research on our platform, helping surface evidence that truly matters. Be part of a human-driven community powered by technology that's designed to move medicine forward.

Turn your curiosity into a meaningful contribution.

Contact Us →